Skip to main content
. 2020 Oct 8;33(14):1010–1045. doi: 10.1089/ars.2020.8060

Table 3.

Patented or Patent-Pending H2S-Releasing Prodrugs

Assignee Drug name Patent number Status
Antibe Holdings, Inc. ATB-346 US8541398B2 September 24, 2013 (granted)
Creighton University University of Nebraska University of Houston System   US8092838B2 January 10, 2012 (granted)
Croma-Pharma GmbH   WO2018083326A1 May 11, 2018 (published)
International Society For Drug Development S.R.L.   WO2019129403A1 July 4, 2019 (published)
Istituto Ortopedico Rizzoli, Universita’ Di Pisa   WO2016071863A1 May 12, 2016 (pending)
National University of Singapore GYY4137 US20100273743A1 September 24, 2013 (granted)
PG-PHARMA LLC DBTS US9662303B2 May 30, 2017 (granted)
Sulfagenix, Inc. SG1002 US8771755B2 July 8, 2014 (granted)
University of Exeter   US10058100B2 August 28, 2018 (granted)
University of New York City Research Foundation   US9688607B2 June 27, 2017 (granted)
University of South Carolina   US20190038643A1 February 7, 2019 (pending)